Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs
- Posted on November 14, 2024
- By South China Morning Post
- 1 Views
Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs
BioNTech says deal will support its push into the development of cancer drugs using its proven mRNA technology.
